✦ LIBER ✦

Neoadjuvant versus Adjuvant Chemotherapy in Patients with Triple Negative Breast Cancer: Predictors of Use and Survival Outcomes

✍ Scribed by C. Kennedy; F. Gao; J.A. Margenthaler

Book ID: 116705827
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 84 KB
Volume: 158
Category: Article
ISSN: 0022-4804
DOI: 10.1016/j.jss.2009.11.195

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant Chemotherapy Is Associated w

Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response

✍ Carla S. Fisher; Cynthia X. Ma; William E. Gillanders; Rebecca L. Aft; Timothy J 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 277 KB

Response to Neoadjuvant Therapy and Long

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

✍ Liedtke, Cornelia (author);Mazouni, Chafika (author);Hess, Kenneth R. (author);A 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 150 KB

Response to Neoadjuvant Therapy and Long

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

✍ Liedtke, Cornelia (author);Mazouni, Chafika (author);Hess, Kenneth R. (author);A 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 150 KB

Predictive factors for the effectiveness

Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients

✍ Hiroko Masuda; Norikazu Masuda; Yoshinori Kodama; Masami Ogawa; Michiko Karita; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 323 KB

Effect of metformin on survival outcomes

Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer

✍ Soley Bayraktar; Leonel F. Hernadez-Aya; Xiudong Lei; Funda Meric-Bernstam; Jenn 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 959 KB

## Abstract ## BACKGROUND: Recent observational studies have shown that metformin use in diabetic patients decreases both cancer incidence and mortality. Metformin use is also independently predictive of pathologic complete response. In the current study, the authors explored the association betwe

Response and long-term effect of patient

Response and long-term effect of patients with triple-negative breast cancer receiving neo-adjuvant anthracycline-based chemotherapy

✍ Sun, Zhengkui (author);Ma, Xingtian (author);Wu, Yudong (author);Fan, Fan (autho 📂 Article 📅 2009 🏛 Springer Science and Business Media LLC ⚖ 355 KB